Alzheimer’s - The Dreaded Disease

Neuron-targeted caveolin-1 overexpression attenuates cognitive loss and pathological transcriptome changes in symptomatic Alzheimer’s disease models

Alzheimer’s disease (AD) is a devastating neurodegenerative disorder characterized by progressive synaptic loss and cognitive decline. Gene therapy that augments intrinsic neuroprotective pathways offers a promising strategy to mitigate neurodegeneration and prevent further cognitive loss. Caveolin-1 (Cav-1), a membrane lipid raft (MLR) scaffolding protein, regulates multiple pro-growth and pro-survival signaling pathways within plasmalemmal mic…

Alzheimer’s - The Dreaded Disease

It’s estimated that 44 million people in the world have Alzheimer’s disease Alzheimer’s disease is the dreaded progressive brain disorder that slowly destroys brain cells causing problems with memory, thinking, and behavior that can affect work, relationships, hobbies, and social life Tasneem Hossain | Bangladesh How would you feel if one day you get up from sleep and your spouse, who has been married with you for 40 years, can’t recognize you?…

Recognizing the signs of Alzheimer’s June 27

Open the article to view the coverage from The Chester Telegraph

SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease

In a recent interview at SNMMI conference, Merle Hoenig, Ph.D., discussed new tau PET research examining genetic and modifiable risk factors that contribute to the progression of Alzheimer’s disease.

Researchers Identify Potential Drug to Treat Alzheimer’s Disease Affecting Over 55 Million Worldwide

Researchers have identified a potential new drug to tre […]